Average Co-Inventor Count = 7.41
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Intellectual Property Gmbh (8 from 721 patents)
2. Bayer Healthcare LLC (2 from 778 patents)
3. Aicuris Gmbh + Co. Kg. (2 from 53 patents)
4. Bayer Pharma Aktiengesellschaft (1 from 378 patents)
13 patents:
1. RE46856 - Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
2. 9422263 - Fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof
3. 9073939 - Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof
4. 9018234 - Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof
5. 8759341 - Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof
6. 8642595 - Annellated 4-(indazolyl)-1,4-dihydropyridine derivatives and methods of use thereof
7. 8604028 - Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof
8. 8551989 - Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereof
9. 8466283 - Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
10. 8143393 - Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
11. 8129379 - Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
12. 7655643 - Antibacterial macrocycles with substituted biphenyl
13. 7446102 - Antibacterial amide macrocycles IV